Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Thrombosis and Haemostasis
|
April 1, 1995
In vitro characterization of high purity factor IX concentrates for the treatment of hemophilia B
S A Limentani, K P Gowell, S R Deitcher
American Journal of Hematology
|
April 1, 1996
Acquired free protein S deficiency associated with multiple myeloma: a case report
S R Deitcher, J K Erban, S A Limentani
Seminars in Thrombosis and Hemostasis
|
January 1, 1993
Recombinant blood clotting proteins for hemophilia therapy
S A Limentani, D A Roth, B C Furie, et al.
Surgical Neurology
|
December 13, 2003
Recurrent primary fibrosarcoma of the brain treated with the GliaSite brachytherapy system: case report
Robert W Fraser, Steven A Limentani, James D Dollar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1985
Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex
H A Liebman, S A Limentani, B C Furie, et al.
Journal of Neuro-Oncology
|
June 7, 2005
A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme
Steven A Limentani, Anthony Asher, Michael Heafner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2007
Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer
Steven A Limentani, Adam M Brufsky, John K Erban, et al.
Clinical Breast Cancer
|
April 6, 2006
Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer
Steven A Limentani, Adam M Brufsky, John K Erban, et al.
Blood
|
November 1, 1987
Separation of human plasma factor IX from HTLV-I or HIV by immunoaffinity chromatography using conformation-specific antibodies
S A Limentani, B C Furie, B J Poiesz, et al.
The Journal of Infectious Diseases
|
May 1, 1995
Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi
M S Klempner, R Noring, M P Epstein, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Thrombosis and Haemostasis
|
April 1, 1995
In vitro characterization of high purity factor IX concentrates for the treatment of hemophilia B
S A Limentani, K P Gowell, S R Deitcher
American Journal of Hematology
|
April 1, 1996
Acquired free protein S deficiency associated with multiple myeloma: a case report
S R Deitcher, J K Erban, S A Limentani
Seminars in Thrombosis and Hemostasis
|
January 1, 1993
Recombinant blood clotting proteins for hemophilia therapy
S A Limentani, D A Roth, B C Furie, et al.
Surgical Neurology
|
December 13, 2003
Recurrent primary fibrosarcoma of the brain treated with the GliaSite brachytherapy system: case report
Robert W Fraser, Steven A Limentani, James D Dollar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1985
Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex
H A Liebman, S A Limentani, B C Furie, et al.
Journal of Neuro-Oncology
|
June 7, 2005
A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme
Steven A Limentani, Anthony Asher, Michael Heafner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2007
Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer
Steven A Limentani, Adam M Brufsky, John K Erban, et al.
Clinical Breast Cancer
|
April 6, 2006
Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer
Steven A Limentani, Adam M Brufsky, John K Erban, et al.
Blood
|
November 1, 1987
Separation of human plasma factor IX from HTLV-I or HIV by immunoaffinity chromatography using conformation-specific antibodies
S A Limentani, B C Furie, B J Poiesz, et al.
The Journal of Infectious Diseases
|
May 1, 1995
Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi
M S Klempner, R Noring, M P Epstein, et al.
Page
of 5